Incontinentia Pigmenti (cont.)Medical Author:
Andrew A. Dahl, MD, FACS
Andrew A. Dahl, MD, FACSAndrew A. Dahl, MD, is a board-certified ophthalmologist. Dr. Dahl's educational background includes a BA with Honors and Distinction from Wesleyan University, Middletown, CT, and an MD from Cornell University, where he was selected for Alpha Omega Alpha, the national medical honor society. He had an internal medical internship at the New York Hospital/Cornell Medical Center. Medical Editor:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology. IN THIS ARTICLEFor More InformationIncontinentia Pigmenti International Foundation |
Women's Health
Find out what women really need.
From WebMD
Parenting & Children's Health Resources
Featured Centers
Read What Your Physician is Reading on Medscape
Incontinentia Pigmenti »
Incontinentia pigmenti (IP) is an X-linked dominant neurocutaneous syndrome with cutaneous, neurologic, ophthalmologic, and dental manifestations.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick,
easy,
pill identification
Find a Local Pharmacy
- including
24 hour
pharmacies

